Adapting, Expanding and Evaluating ARCHES in Kenya

October 29, 2024 updated by: Jay G. Silverman, PhD, University of California, San Diego

Adapting, Expanding, and Evaluating ARCHES (Addressing Reproductive Coercion in Health Settings) in Kenya

Document evidence, via cluster randomized controlled trial, of the effectiveness of the ARCHES intervention, a brief, clinic-based counselling intervention demonstrated to reduce intimate partner violence and reproductive coercion and promote women's reproductive health, as scaled in government health facilities in Kenya, to (1) decrease unintended pregnancy, (2) increase family planning uptake and use/continuation, (3) decrease experiences of reproductive coercion and intimate partner violence of women and girls aged 15 to 49 years seeking family planning services, and, to (4) improve quality of care, (5) increase gender equitable attitudes, and, (6) increase self-efficacy to provide comprehensive family planning counseling among providers trained in ARCHES.

Study Overview

Detailed Description

Background: In Kenya, 17% of women have unmet need for family planning (FP) and the modern contraceptive prevalence rate (mCPR) has plateaued around 45%, contributing to poor reproductive health outcomes. This includes the nearly 50% of women in Kenya who report their last pregnancy as unintended, with those experiencing gender-based violence (GBV), particularly in the forms of intimate partner violence (IPV) and reproductive coercion (RC; behaviors that reduce women's ability to use contraception or otherwise prevent pregnancy), at significantly greater risk. Similar to other LMIC settings, both RC and IPV are highly prevalent in Kenya, particularly among women seeking FP and other reproductive health services (>1/3 of female FP clients). Since 2013, the World Health Organization (WHO) has strongly recommended that IPV and RC be addressed within reproductive health services and, in 2018, the Lancet Commission on Sexual and Reproductive Health and Rights found that RC and IPV were a significant contributor to unmet need for FP and unintended pregnancy, with greatest impacts among women and girls in LMICs. Within Kenya, the Ministry of Health (MOH) has made reduction of unintended pregnancy and gender-based violence (GBV), especially among adolescents, a primary objective. Despite this need and guidance, no clinic-based intervention models outside of the U.S. (apart from one, ARCHES) have demonstrated efficacy to improve FP uptake/use and reduce IPV or RC thereby reducing unintended pregnancy.

Intervention Description: ARCHES (Addressing Reproductive Coercion in Health Settings) is a brief, clinic-based intervention delivered by family planning providers aiming to: 1) Increase women's and girls' ability to use family planning in the face of reproductive coercion, facilitating women's voluntary family planning uptake and continued use without interference, 2) Provide a safe and supportive environment for IPV disclosure and subsequent referral to support services, and 3) Educate and support providers to improve quality of care related to family planning counseling, including addressing reproductive coercion and intimate partner violence.

Objective: The objective of this study is to generate evidence and learnings on scaling integrated family planning services (including family planning, reproductive coercion, and intimate partner violence) in public sector health facilities in Uasin Gishu County, Kenya via adaptation and implementation of ARCHES, in partnership with the Kenya MOH.

Methodology: A cluster randomized controlled trial paired with concurrent implementation science assessments will test effectiveness of the ARCHES model that has been adapted for scale by the Kenya MOH. Female family planning clients aged 15-49 years at selected sites will complete baseline surveys (immediately prior to receiving care), immediately post-visit exit surveys, and 6-month follow-up surveys. Family planning providers trained in ARCHES will complete pre-training, post-training, and 3-month follow-up surveys to assess changes in gender-equitable attitudes and self-efficacy to address issues of violence among their clients. Costs associated with the scale-up strategy will be tracked and utilized in combination with results of the effectiveness trial to assess total cost and cost-effectiveness of ARCHES.

Study Type

Interventional

Enrollment (Actual)

3928

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Burnt Forest, Kenya
        • Burnt Forest Sub-county Hospital
      • Burnt Forest, Kenya
        • Kipkabus Health Centre
      • Cheptiret, Kenya
        • Chepkigen Health Centre
      • Eldoret, Kenya
        • Huruma District Hospital
      • Eldoret, Kenya
        • Kapsoya Health Centre
      • Eldoret, Kenya
        • Kapteldon Health Centre
      • Eldoret, Kenya
        • Kapyemit Dispensary
      • Eldoret, Kenya
        • Kipkenyo
      • Eldoret, Kenya
        • Pioneer Health Centre
      • Eldoret, Kenya
        • Railways
      • Eldoret, Kenya
        • Uasin Gishu District Hospital
      • Kesses, Kenya
        • Kesses Health Centre
      • Kimumu, Kenya
        • Chembulet Health Centre
      • Kimumu, Kenya
        • Chepkanga Health Centre
      • Kimumu, Kenya
        • Merewet Dispensary
      • Moi's Bridge, Kenya
        • Moi's Bridge Health Centre
      • Moiben, Kenya
        • Moiben Health Centre
      • Naiberi, Kenya
        • Chepkero Dispensary
      • Soy, Kenya
        • Soy Health Centre
      • Turbo, Kenya
        • Sosiani Health Centre
      • Turbo, Kenya
        • Turbo Sub-County Hospital
      • Ziwa, Kenya
        • Kabobo Health Centre
      • Ziwa, Kenya
        • Kipsigak Health Centre
      • Ziwa, Kenya
        • Ziwa Sub-County Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Description

All eligibility criteria based on self-report.

Inclusion Criteria:

  • Seeking family planning services at a selected study facility
  • Aged 15-49 years old
  • Female
  • Able to provide informed consent
  • Able to speak and understand English, Kiswahili, or Kalenjin
  • Able to provide a safe phone number at which they can be recontacted for follow-up
  • Not planning to move out of the area in the coming 6 months

Exclusion Criteria:

  • Sterilized at baseline
  • Pregnant at baseline

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Control - Standard contraceptive counseling
Standard contraceptive counseling, includes provider training on standard BCS+ counseling protocol and use of a companion mobile application to guide counseling
BCS+ (Balanced Counseling Strategy Plus) is a contraceptive counseling protocol that contraceptive providers use to help clients identify suitable contraceptive methods based on their preferences and previous contraceptive experiences. The BCS+ also includes systematic screening for other health services such as HIV/STI, cervical cancer, and breast cancer. The BCS+ was adopted by the Kenya MOH as the standard contraceptive counseling protocol in the country.
Experimental: Intervention - Integrated contraceptive counseling
Integrated contraceptive counseling, includes provider training on ARCHES integrated in BCS+ counseling protocol and use of a companion mobile application to guide counseling
BCS+ (Balanced Counseling Strategy Plus) is a contraceptive counseling protocol that contraceptive providers use to help clients identify suitable contraceptive methods based on their preferences and previous contraceptive experiences. The BCS+ also includes systematic screening for other health services such as HIV/STI, cervical cancer, and breast cancer. The BCS+ was adopted by the Kenya MOH as the standard contraceptive counseling protocol in the country.
ARCHES (Addressing Reproductive Coercion in Health Settings) includes training existing contraceptive providers to (1) provide contraceptive clients with education on reproductive coercion and methods/ways to use contraceptive methods covertly if desired, (2) provide screening for reproductive coercion and intimate partner violence, (3) provide a referral to specialized services for those disclosing intimate partner violence, (4) and offer a palm-sized mini-booklet with educational information on reproductive coercion and intimate partner violence. A mobile application was developed to guide contraceptive providers through the counselling protocol.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incident unintended pregnancy
Time Frame: 6-month follow-up
Difference in self-reported unintended pregnancy in the past 6 months at the 6-month follow-up in intervention compared to control group (single time point analysis)
6-month follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Modern contraceptive use in the past 6 months
Time Frame: Baseline (at facility prior to receiving care) and 6-month follow-up
Change in prevalence of self-reported modern contraceptive use in the past 6 months between baseline and 6-month follow-up in intervention compared to control group (difference-in differences)
Baseline (at facility prior to receiving care) and 6-month follow-up
Physical intimate partner violence in the past 6 months
Time Frame: Baseline (combined report at facility prior to receiving care and report at facility immediately after receiving care (post-visit); combined due to increased reporting post-visit) and 6-month follow-up
Change in prevalence of self-reported physical intimate partner violence experience in the past 6 months between combined baseline/post-visit and 6-month follow-up in intervention compared to control group (difference-in differences)
Baseline (combined report at facility prior to receiving care and report at facility immediately after receiving care (post-visit); combined due to increased reporting post-visit) and 6-month follow-up
Sexual intimate partner violence in the past 6 months
Time Frame: Baseline (combined report at facility prior to receiving care and report at facility immediately after receiving care (post-visit); combined due to increased reporting post-visit) and 6-month follow-up
Change in prevalence of self-reported sexual intimate partner violence experience in the past 6 months between combined baseline/post-visit and 6-month follow-up in intervention compared to control group (difference-in differences)
Baseline (combined report at facility prior to receiving care and report at facility immediately after receiving care (post-visit); combined due to increased reporting post-visit) and 6-month follow-up
Emotional intimate partner violence in the past 6 months
Time Frame: Baseline (combined report at facility prior to receiving care and report at facility immediately after receiving care (post-visit); combined due to increased reporting post-visit) and 6-month follow-up
Change in prevalence of self-reported emotional intimate partner violence experience in the past 6 months between combined baseline/post-visit and 6-month follow-up in intervention compared to control group (difference-in differences)
Baseline (combined report at facility prior to receiving care and report at facility immediately after receiving care (post-visit); combined due to increased reporting post-visit) and 6-month follow-up
Reproductive coercion from a male partner in the past 6 months
Time Frame: Baseline (combined report at facility prior to receiving care and report at facility immediately after receiving care (post-visit); combined due to increased reporting post-visit) and 6-month follow-up
Change in prevalence of self-reported reproductive coercion experience in the past 6 months between combined baseline/post-visit and 6-month follow-up in intervention compared to control group (difference-in differences)
Baseline (combined report at facility prior to receiving care and report at facility immediately after receiving care (post-visit); combined due to increased reporting post-visit) and 6-month follow-up
Incident pregnancy
Time Frame: 6-month follow-up
Difference in self-reported pregnancy in the past 6 months at the 6-month follow-up in intervention compared to control group (single time point analysis)
6-month follow-up
Uptake of a modern contraceptive method
Time Frame: Post-visit (at facility immediately after receiving care)
Difference in prevalence of self-reported modern contraceptive uptake post-visit in intervention compared to control group (single time point analysis)
Post-visit (at facility immediately after receiving care)
Covert use of contraception in the past 6 months
Time Frame: Baseline (at facility prior to receiving care) and 6-month follow-up
Change in prevalence of self-reported covert contraceptive use in the past 6 months between baseline and 6-month follow-up in intervention compared to control group (difference-in differences)
Baseline (at facility prior to receiving care) and 6-month follow-up
Contraceptive self-efficacy in the face of reproductive coercion
Time Frame: Baseline (at facility prior to receiving care), Post-visit (at facility immediately after receiving care), and 6-month follow-up
Change in mean self-efficacy score (range: 3-9, higher=higher self-efficacy) between baseline, post-visit, and 6-month follow-up in intervention compared to control group (difference-in differences)
Baseline (at facility prior to receiving care), Post-visit (at facility immediately after receiving care), and 6-month follow-up
Awareness of intimate partner violence services
Time Frame: Baseline (at facility prior to receiving care), Post-visit (at facility immediately after receiving care), and 6-month follow-up
Change in prevalence of awareness of intimate partner violence services between baseline, post-visit, and 6-month follow-up in intervention compared to control group (difference-in differences)
Baseline (at facility prior to receiving care), Post-visit (at facility immediately after receiving care), and 6-month follow-up
Self-efficacy to use intimate partner violence services
Time Frame: Baseline (at facility prior to receiving care), Post-visit (at facility immediately after receiving care), and 6-month follow-up
Change in mean self-efficacy score (range: 1-3, higher=higher self-efficacy) between baseline, post-visit, and 6-month follow-up in intervention compared to control group (difference-in differences)
Baseline (at facility prior to receiving care), Post-visit (at facility immediately after receiving care), and 6-month follow-up
Use of intimate partner violence services
Time Frame: 6-month follow-up
Difference in prevalence of use of intimate partner violence services in the past 6 months at the 6-month follow-up in intervention compared to control group (single time point analysis)
6-month follow-up
Attitudes accepting of reproductive coercion
Time Frame: Baseline (at facility prior to receiving care), Post-visit (at facility immediately after receiving care), and 6-month follow-up
Change in mean attitude score (range: 6-12, higher=attitudes less accepting of reproductive coercion/improved attitudes) between baseline, post-visit, and 6-month follow-up in intervention compared to control group (difference-in differences)
Baseline (at facility prior to receiving care), Post-visit (at facility immediately after receiving care), and 6-month follow-up
Quality of family planning care
Time Frame: Post-visit (at facility immediately after receiving care)
Difference in mean (range: 11-55, higher=higher quality) interpersonal quality of family planning scale post-visit in intervention compared to control group (single time point analysis)
Post-visit (at facility immediately after receiving care)
Discontinuation of modern contraception
Time Frame: 6-month follow-up
Difference in prevalence of modern contraceptive discontinuation in the past 6 months at the 6-month follow-up in intervention compared to control group (single time point analysis)
6-month follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jay G Silverman, PhD, University of California, San Diego

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 29, 2023

Primary Completion (Actual)

May 17, 2024

Study Completion (Actual)

May 17, 2024

Study Registration Dates

First Submitted

September 6, 2023

First Submitted That Met QC Criteria

September 22, 2023

First Posted (Actual)

September 28, 2023

Study Record Updates

Last Update Posted (Estimated)

November 1, 2024

Last Update Submitted That Met QC Criteria

October 29, 2024

Last Verified

October 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Will share de-identified participant data analysis sets to the Dyrad public data repository upon publication of findings

IPD Sharing Time Frame

Upon publication of findings

IPD Sharing Access Criteria

Open access

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • ANALYTIC_CODE

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Intimate Partner Violence

Clinical Trials on BCS+ (Balanced Counseling Strategy Plus)

Subscribe